U K appeals court affirms HC ruling in Ranbaxy-Pfizer case

28 Jun 2006

1

Mumbai: The UK Court of Appeal has upheld an October 2005 ruling of the UK High Court in Ranbaxy Laboratories' case against (Pfizer) Warner-Lambert over the cholesterol-lowering drug, atorvastatin, which is marketed by Pfizer as Lipitor, Ranbaxy said on Wednesday.

The three-judge panel confirmed that (Pfizer) Warner-Lambert's European Patent 409 281 was invalid in the UK. However, the company's atorvastatin product was ruled to infringe the broadest claims of (Pfizer) Warner-Lambert's European patent 247 633 in the UK. The company is evaluating this decision and will decide on its course of action shortly.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more